Amgen Tax Liabilities vs PPandE Turnover Analysis

AMGN Stock  USD 286.30  4.53  1.61%   
Trend analysis of Amgen Inc balance sheet accounts such as Short Long Term Debt Total of 67.8 B, Other Current Liabilities of 16.1 B or Total Current Liabilities of 19.3 B provides information on Amgen's total assets, liabilities, and equity, which is the actual value of Amgen Inc to its prevalent stockholders. By breaking down trends over time using Amgen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

About Amgen Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Amgen Inc at a specified time, usually calculated after every quarter, six months, or one year. Amgen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Amgen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Amgen currently owns. An asset can also be divided into two categories, current and non-current.

Amgen Balance Sheet Chart

Amgen Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Amgen Inc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Amgen's Cash is very stable compared to the past year. As of the 28th of March 2024, Non Current Assets Total is likely to grow to about 70.2 B, while Property Plant And Equipment Net is likely to drop about 3.6 B.

Total Assets

Total assets refers to the total amount of Amgen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Amgen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Amgen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Amgen Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Amgen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amgen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
At this time, Amgen's Selling General Administrative is very stable compared to the past year. As of the 28th of March 2024, Tax Provision is likely to grow to about 1.4 B, while Enterprise Value Multiple is likely to drop 9.83.
 2021 2022 2023 2024 (projected)
Interest Expense1.2B1.4B2.9B3.0B
Depreciation And Amortization3.4B3.4B4.1B4.3B

Amgen fundamental ratios Correlations

0.930.740.810.330.650.94-0.40.670.860.630.350.78-0.490.92-0.190.470.910.630.520.260.760.810.790.370.77
0.930.890.91-0.010.470.99-0.610.830.950.840.020.94-0.550.99-0.250.720.990.810.210.120.950.820.640.080.6
0.740.890.95-0.370.390.85-0.880.930.920.95-0.30.99-0.730.92-0.210.840.940.9-0.07-0.060.930.880.58-0.290.54
0.810.910.95-0.230.470.88-0.810.870.90.83-0.120.94-0.760.92-0.290.730.950.820.10.250.880.890.67-0.120.63
0.33-0.01-0.37-0.230.390.070.66-0.35-0.12-0.440.88-0.290.37-0.050.17-0.51-0.09-0.360.790.36-0.27-0.110.310.880.36
0.650.470.390.470.390.46-0.320.420.470.210.40.4-0.530.480.220.10.490.350.630.280.30.590.960.270.95
0.940.990.850.880.070.46-0.530.760.930.790.090.89-0.510.98-0.320.680.970.760.270.170.920.80.630.160.59
-0.4-0.61-0.88-0.810.66-0.32-0.53-0.85-0.71-0.810.56-0.820.79-0.660.13-0.74-0.7-0.790.330.11-0.72-0.76-0.460.62-0.43
0.670.830.930.87-0.350.420.76-0.850.850.88-0.310.94-0.580.850.080.790.870.87-0.1-0.10.890.770.56-0.320.51
0.860.950.920.9-0.120.470.93-0.710.850.88-0.180.95-0.650.96-0.260.740.960.830.040.010.940.850.65-0.140.61
0.630.840.950.83-0.440.210.79-0.810.880.88-0.440.95-0.610.86-0.220.90.860.91-0.24-0.280.930.740.39-0.390.34
0.350.02-0.3-0.120.880.40.090.56-0.31-0.18-0.44-0.260.210.00.09-0.48-0.03-0.340.940.49-0.28-0.010.350.970.39
0.780.940.990.94-0.290.40.89-0.820.940.950.95-0.26-0.650.95-0.170.840.960.91-0.04-0.040.970.840.58-0.230.53
-0.49-0.55-0.73-0.760.37-0.53-0.510.79-0.58-0.65-0.610.21-0.65-0.610.39-0.5-0.65-0.6-0.07-0.14-0.51-0.81-0.680.31-0.65
0.920.990.920.92-0.050.480.98-0.660.850.960.860.00.95-0.61-0.260.721.00.810.20.070.930.880.670.040.62
-0.19-0.25-0.21-0.290.170.22-0.320.130.08-0.26-0.220.09-0.170.39-0.26-0.2-0.27-0.130.06-0.26-0.2-0.280.03-0.010.05
0.470.720.840.73-0.510.10.68-0.740.790.740.9-0.480.84-0.50.72-0.20.730.96-0.31-0.250.840.590.24-0.420.18
0.910.990.940.95-0.090.490.97-0.70.870.960.86-0.030.96-0.651.0-0.270.730.830.180.110.930.890.680.010.63
0.630.810.90.82-0.360.350.76-0.790.870.830.91-0.340.91-0.60.81-0.130.960.83-0.13-0.160.870.730.47-0.320.43
0.520.21-0.070.10.790.630.270.33-0.10.04-0.240.94-0.04-0.070.20.06-0.310.18-0.130.5-0.090.220.60.890.61
0.260.12-0.060.250.360.280.170.11-0.10.01-0.280.49-0.04-0.140.07-0.26-0.250.11-0.160.5-0.070.050.310.470.32
0.760.950.930.88-0.270.30.92-0.720.890.940.93-0.280.97-0.510.93-0.20.840.930.87-0.09-0.070.740.47-0.190.4
0.810.820.880.89-0.110.590.8-0.760.770.850.74-0.010.84-0.810.88-0.280.590.890.730.220.050.740.77-0.050.76
0.790.640.580.670.310.960.63-0.460.560.650.390.350.58-0.680.670.030.240.680.470.60.310.470.770.240.99
0.370.08-0.29-0.120.880.270.160.62-0.32-0.14-0.390.97-0.230.310.04-0.01-0.420.01-0.320.890.47-0.19-0.050.240.26
0.770.60.540.630.360.950.59-0.430.510.610.340.390.53-0.650.620.050.180.630.430.610.320.40.760.990.26
Click cells to compare fundamentals

Amgen Account Relationship Matchups

Amgen fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets59.7B62.9B61.2B65.1B97.2B102.0B
Short Long Term Debt Total29.9B33.0B33.3B38.9B64.6B67.8B
Other Current Liab8.5B10.1B10.7B12.5B15.4B16.1B
Total Current Liabilities12.8B11.7B12.2B15.7B18.4B19.3B
Total Stockholder Equity9.7B9.4B6.7B3.7B6.2B12.3B
Property Plant And Equipment Net4.9B4.9B5.2B5.4B5.9B3.6B
Net Debt23.9B26.7B25.3B31.3B53.7B56.4B
Retained Earnings(21.3B)(21.4B)(24.6B)(28.6B)(26.5B)(25.2B)
Cash6.0B6.3B8.0B7.6B10.9B11.5B
Non Current Assets Total41.3B41.8B41.8B42.9B66.8B70.2B
Non Currrent Assets Other2.2B5.6B6.5B5.9B9.6B10.1B
Cash And Short Term Investments8.9B10.6B8.0B9.3B10.9B10.5B
Net Receivables4.1B4.5B4.9B5.6B7.9B8.3B
Common Stock Shares Outstanding609M590M573M541M538M759.2M
Liabilities And Stockholders Equity59.7B62.9B61.2B65.1B97.2B102.0B
Non Current Liabilities Total37.2B41.9B42.3B45.8B72.5B76.2B
Other Current Assets1.9B2.1B2.4B2.4B281M267.0M
Other Stockholder Equity(528M)(985M)18.2B21.7B25.0B26.2B
Total Liab50.0B53.5B54.5B61.5B90.9B95.5B
Property Plant And Equipment Gross4.9B4.9B14.0B14.7B15.7B16.5B
Total Current Assets18.4B21.1B19.4B22.2B30.3B15.2B
Accumulated Other Comprehensive Income(528M)(985M)(796M)(231M)(289M)(274.6M)
Short Term Debt3.0B91M87M1.6B1.4B1.0B
Inventory3.6B3.9B4.1B4.9B9.5B10.0B
Accounts Payable1.4B1.4B1.4B1.6B1.6B1.7B
Common Stock Total Equity31.5B31.8B32.1B32.5B37.4B27.1B
Short Term Investments2.9B4.4B48M1.7B10.9B12.2B
Common Stock31.5B31.8B32.1B32.5B33.1B27.5B
Other Assets955M1.3B6.5B2.2B2.5B1.4B
Long Term Debt27.0B32.9B33.2B37.4B63.2B66.3B
Property Plant Equipment4.9B4.9B5.2B5.4B6.2B5.3B
Good Will14.7B14.7B14.9B15.5B18.6B14.4B
Intangible Assets19.4B16.6B15.2B16.1B32.6B34.3B
Other Liab9.9B9.0B9.1B7.9B9.1B5.1B
Net Tangible Assets(24.4B)(21.9B)(23.4B)(27.9B)(25.2B)(23.9B)
Retained Earnings Total Equity(21.3B)(21.4B)(24.6B)(28.6B)(25.8B)(24.5B)
Long Term Debt Total27.0B32.9B33.2B37.4B43.0B29.9B
Non Current Liabilities Other9.6B9.0B2.5B2.7B2.3B2.2B

Pair Trading with Amgen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Amgen Stock

  0.62MBIO Mustang Bio Report 3rd of April 2024 PairCorr

Moving against Amgen Stock

  0.76EQ Equillium Financial Report 9th of May 2024 PairCorr
  0.73TCRX Tscan Therapeutics Financial Report 8th of May 2024 PairCorr
  0.65DNLI Denali Therapeutics Financial Report 13th of May 2024 PairCorr
  0.6VANI Vivani Medical Report 29th of March 2024 PairCorr
  0.56MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.52)
Dividend Share
8.52
Earnings Share
12.48
Revenue Per Share
52.692
Quarterly Revenue Growth
0.198
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.